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Fab fragments of anti-apamin monoclonal antibodies have been purified to homogeneity and crystallized. The crystals belong to the monoclinic 
space group P2, with cell dimensions a = 99.0 + 0.3 A, 6 = 137.1 5 0.4 A, c = 76.0 f0.2 A and /3=92.9+0.9”. They most likely contain four molecules 
in the asymmetric unit (V,,,=2.39 &/Da). The possibility of the existence of non-crystallographic symmetry is discussed. 
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1. INTRODUCTION 
X-ray crystallography has been extensively used to 
determine the three-dimensional structures of 
monoclonal immunoglobulin fragments (Fab) and, 
more recently, structures of Fab/protein antigen com- 
plexes. This has greatly contributed to our understan- 
ding of the molecular basis of antibody-antigen 
recognition (reviews [1,2]). Five such structure deter- 
minations have already been reported: three 
lysozyrne/Fab complexes [3-S] and two influenza virus 
neuraminidase/Fab complexes 161. The epitopes analys- 
ed were all discontinuous, each contained between 15 
and 22 residues, and had a buried surface of 
650-900 A’. The paratopes appeared to be rather flat 
surfaces. The structure of one Fab/hapten complex has 
also been investigated 171. In this case the paratope ap- 
pears to be a groove into which the hapten fits. The way 
a peptide interacts with the paratope of its specific an- 
tibody is not well understood. The only relevant 
reported study is that of a complex between a Fab and 
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a synthetic peptide analog of the C-helix of 
myohemerythrin [$I. 
Apamin, a toxin isolated from bee venom (&is 
mellife&, is a small polypeptide of 18 amino acids (Mr 
= 2039) (review [9]). It specifically blocks a class of 
Caz f -dependent Ke channels [ 101. Nuclear magnetic 
resonance and circular dichroism studies have depicted 
the compact structure of apamin in solution [l l-131. 
This type of molecule is of particular interest for study- 
ing the immune response to peptides and we have conse- 
quently used it as a model antigen. We have found that 
I3 and T cell responses to apamin are under the genetic 
control of the major histocompatibility complex 
[ 14,151. A panel of 20 monoclonal antibodies (mAbs) 
have been raised against free apamin (mAbs H201) or 
BSA-coupled apamin (mAbs H196) and their fine 
epitope specificity has been determined using synthetic 
apamin analogs [16], To contribute to the understan- 
ding of the nature of the interface established between 
a peptide and the combining site on a specific antibody, 
we have undertaken the purification of several anti- 
apamin mAbs with the goal of crystallizing Fabs and 
Fab/apamin complexes. In this paper we describe ex- 
tensive purification, preparation and crystallization 
trials of the N196-293 mAb-derived Fab fragment 
\I8&y;,M) which binds apamin with an affinity of 3 x 
. 
2. MATERIALS AND METHODS 
Anti-apamin IILMI (t-I 196-293) ~a prepared iIS dcrcribed [lb). 
Aseitic fluid was passed through a pratcin A&pharose column 
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(Pharmacia) in 3 M NaCI, 1.5 M glycine, pH 8.9, and the bound IgGs 
were eluted with 0.1 M sodium citrate, pH 6. Fab fragments were ob- 
tained by papain digestion and partial purification on a Sephadex 
G-100 column according to the genera1 procedure [17]. lsoforms of 
Fab were separated by FPLC (Mono Q column, Pharmacia) using a 
linear pW gradient [18]. Optimal separation was obtained by a 20 mM 
ethanolamine. pH 9.0/20 Wvl triethanolamine, pH 7.5 gradient, over 
a period of 180 min. Fractions of each isoform were collected and 
concentrated by vacuum dialysis to about 10 mg/ml in 5 mM 
HEPES, pH 6.8. In one case a further increase in purity was obtained 
using a cation exchange column (Mono S, Pharmacia) and a 20 mM 
MES, p1-i 5.8/20 mM HEPES, pH 7.6 gradient. Purity was checked 
at each step by SDS-polyacrylamide gel electrophoresis and by 
isoelectrofocusing (IEF; PhastSystem, Pharmacia). 
Crystallization experiments were performed by the hanging drop 
vapor diffusion method at 2O”C, initially using the incomplete fac- 
torial experimental design described by Carter et al. [19]. Once 
crystals had grown, crystallization conditions were refined by 
systematically testing a range of closely related conditions. 
3. RESULTS AND DISCUSSION 
Analysis of the Fab fraction by IEF showed three ma- 
jor isoforms of pI 8.3, 7.8 and 7.4 which were named I, 
II and III, respectively. They were purified by FPLC to 
90-95% homogeneity. Each isoform was still able to 
bind to apamin as indicated by the increase in the 
observed p1 of isoforms complexed with apamin. This 
was due to the highly basic character of apamin 
(Fig. I). Crystals were obtained only when PEG 6000 
was used as precipitant. Two suitable ranges of condi- 
tions were found for isoform II: (i) 15% PEG (w/v), 
PI-I 7.4-8.1 with or without 0.1 M NaCl; (ii) ii-IO% 
PEG (w/v), PI-I 5.4-6.4, with or without either 0.1 M 
NaCI or 0.2 M ammonium sulfate. Crystals of isoform 
III grew between 10% and 15% PEG (w/v), PI-I 5.4-7.4 
with 0.1 M NaCl. Isoform I did not crystallize in these 
experiments. 
The best crystals were obtained with isoform II 
(5 mg/ml) in 13% PEG (w/v), 50 mM sodium 
phosphate, pH 7.7, and 50 mM NaCI. They grew as 
thin, roughly rectangular plates (0.200 x 0.100 x 
0.020 mm), that diffracted to at least 3.5 A resolution. 
Precession photographs indicated that they belong to 
the monoclinic space group p21 with cell dimensions 
a = 99.0 + 0.3 A, b = 137.1 & 0.4 A, c = 76.0 f 0.2 A 
and ,LY = 92.9 2 0.9’. Assuming that each asymmetric 
unit contains four molecules (approximate Mr 50000 
per polypeptide molecule) a V,,, = 2.39 A3/Da is obtain- 
ed. This value is within the range generally observed for 
protein crystals [20], Data from one of the crystals was 
collected in a Xentronics/Siemens area detector using a 
Rigaku RU 200 rotating anode generator as the X-ray 
source. Data reduction was carried out using the 
XENGEN package [21]. A total of 7727 independent 
reflections were obtained from 35926 observations. 
This constitutes 80% of the theoretically possible reflec- 
tions at 3.8 A. The unwcighted absolute value R factor 
on intensities (R3 of XENGEN) is 0.155 at this resolu- 
tion. 
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Fig. I. Comparative electrophoretic migration in an IEF gel of the 
different isoforms of Fab H196-293 and of their complexes with 
apamin. Proteins were purified by FPLC (Mono Q column) as 
described in the text. (Lanes l-3) Isoforms I, II and III respectively 
(15 ng each). (Lanes 4-6) Complexes of isoforms I (lane 4), II (lane 
5) and 111 (lane G) with apamin (ratio I: 1.5) after overnight 
incubation. The banding pattern was revealed by silver staining. 
To explore the possibility that the four Fab molecules 
in the asymmetric unit are related by non- 
crystallographic symmetry operations, the self-rotation 
function was calculated using the program ROTFUN 
[22,23]. The 180” rotation section of this function 
shows a strong 222 point symmetry (Fig. 2). The 
heights of the peaks corresponding to the non- 
crystallographic dyads (in the periphery of the 
stereographic projection shown in Fig. 2) are about 
60% of that of the origin peak. I3ased on this observa- 
tion, the whole data set was re-indexed with all unit cell 
angles constrained to 90”. The orientation matrices ob- 
tained in these calculations systematically showed 
a % 
Fig. 2. Stereographic projection (180” rotation section) of the self- 
rotation function looking down lhc crystallographic 6 axis. Contours 
draw cvcry two roo[-mm~-square (KMS) deviations of ~lte whole 
rotation function map. 
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statistics that were worse than those obtained when us- 
ing the monoclinic cell parameters described above. 
This pseudo-orthorhombic symmetry will be of great 
value in interpreting molecular replacement search 
functions, as only two essentially independent orienta- 
tions should be found for the Fab molecule in the unit 
cell. 
Fab/apamin complexes were prepared by mixing Fab 
and apamin solutions in several molar ratios (from 1: 1 
to 1 :5). They were assayed for crystallization directly 
or after purification on a Mono Q column. Many dif- 
ferent sets of conditions were tried, but no crystals of 
Fab/apamin complexes were obtained with any of the 
isoform or mAb used. The complexes induced a phase 
separation in PEG solutions and amorphous 
precipitates in MPD, but seemed fairly soluble in saline 
solutions. Large-scale production of Fab and of their 
complexeP with apamin is proceeding to facilitate the 
search for crystallization conditions for the complexes. 
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